Abbott Laboratories (ABT)
Principal business is the discovery, development, manufacture and sale of a broad and diversified line of health care products. Company has four segments: Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Vascular Products.
Recs
legal & contractual issues
Recs
I just have a sneaking feeling...
Recs
Gota love the little things in life
Recs
I wish I had owned this stock last year....
Recs
Love the dividends and the slow steady growth but it won't outperform the S & P
Recs
IT IS DOWN RIGHT NOW BUT RATED AS A DEFENSIVE STOCK
Recs
lawsuits and layoffs.
Recs
Too many lawsuits happening with prescription drugs. Layoffs are happening often.
Recs
Tired of waiting.
Recs
I think Abbott Labs has reached it's current peak and will underperform the S&P over the next 3 years.
Recs
Will fall back to 40s
Recs
heavy competition
Recs
Idaho has filed a lawsuit that alleges Abbott Laboratories falsified wholesale drug prices and that the state has overpaid Medicaid reimbursements because of the manipulated drug prices. In the complaint, the Idaho attorney general's office says the prices charged to hospitals and pharmacies for Abbott's prescription drugs were less than what the company reported to the state. About 175,000, an estimated 8-10% of the population, people in Idaho currently receive Medicaid benefits. This is most likely not an isolated incident and, in my experience, the Idaho AG's office has not moved against companies in consumer protection issues haphazardly.
Recs
Overpriced and they don't make much money. They pay more of their profits out as divdends than they reinvest in themselves, so growth won't be as big as you might think. 50 p/e is way too high.
Recs
The Democrats are coming! The Democrats are coming!

RSS Headlines
Fool UK
- Show Me:
-
Outperform
-
Underperform
-
All
- Sort by:
-
Author
-
Recs
-
Date
-
Member Rating
-
Results 1 - 15 of 15